Skip to main content
Berry Genomics Co.,Ltd logo

Berry Genomics Co.,Ltd — Investor Relations & Filings

Ticker · 000710 ISIN · CNE000000PN7 Shenzhen Stock Exchange Professional, scientific and technical activities
Filings indexed 2,009 across all filing types
Latest filing 2022-04-14 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 000710

About Berry Genomics Co.,Ltd

https://www.berrygenomics.com

Berry Genomics Co.,Ltd. is a biotechnology enterprise specializing in clinical genomics and genetic testing services. The company focuses on the research, development, and commercialization of genomic technologies for clinical applications. Its core portfolio includes non-invasive prenatal testing (NIPT), utilizing high-throughput sequencing to screen for chromosomal abnormalities. Beyond reproductive health, the company provides genomic solutions for oncology diagnostics, including early cancer screening and companion diagnostics, as well as testing for hereditary diseases. Berry Genomics leverages advanced sequencing platforms and proprietary bioinformatics pipelines to deliver precision medicine tools to healthcare providers and research institutions. The company is recognized for its role in the clinical application of Next-Generation Sequencing (NGS) and its extensive genomic databases used to enhance diagnostic accuracy and therapeutic outcomes.

Recent filings

Filing Released Lang Actions
2021年年度审计报告
Regulatory Filings
2022-04-14 Chinese
年度股东大会通知
AGM Information Classification · 95% confidence The document is a detailed notice about the convening of the 2021 Annual General Meeting (AGM) of the company, including meeting time, location, voting procedures, agenda items, and instructions for shareholders. It references the 2021 annual report and other related reports as agenda items to be discussed and voted on at the meeting, but does not contain the reports themselves. The document is essentially an announcement and procedural guide for the AGM, not the actual annual report or financial statements. The length is about 4661 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits the category of AGM Information (AGM-R).
2022-04-14 Chinese
关于为全资子公司提供担保的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the provision of a guarantee by the parent company for its wholly owned subsidiary's bank credit facility. It includes details about the guarantee amount, terms, the subsidiary's financial data, board approval, and independent director opinions. The document is relatively short (2106 characters) and focuses on a specific financing-related event (providing a guarantee). It does not contain comprehensive financial statements or detailed financial performance analysis typical of annual or interim reports. It is not a report itself but an announcement about a financing-related guarantee. Therefore, it fits best under Capital/Financing Update (CAP).
2022-04-14 Chinese
2021年度财务决算报告
Annual Report Classification · 95% confidence The document is titled as the '2021年度财务决算报告' which translates to '2021 Annual Financial Settlement Report'. It contains detailed financial data including income, costs, assets, liabilities, cash flow, and financial ratios for the full year 2021. The document also includes a financial budget for 2022. The length is over 5,000 characters and contains substantive financial data and analysis, not just an announcement or certification. There is no indication that this is a short announcement or a certification letter. The content matches the characteristics of an Annual Report (10-K) as it covers the full fiscal year financial performance and detailed financial statements. Therefore, the appropriate classification is Annual Report (10-K). FY 2021
2022-04-14 Chinese
独立董事关于聘请公司2022年度审计机构的独立意见
Audit Report / Information Classification · 95% confidence The document is an independent director's opinion on the appointment of the 2022 annual audit firm for the company. It references regulatory rules and governance standards related to audit firm appointment and confirms the continuation of the current auditor for the next fiscal year. The document does not contain actual financial statements or detailed audit results but is an opinion and approval related to audit firm appointment. This fits the category of Audit Report / Information (AR), which includes standalone audit reports and related audit information excluding full annual reports. The document length is short and it is not a mere announcement of a report publication, so it is not RPA. It is not a certification letter or regulatory filing. Therefore, the best classification is AR with high confidence. FY 2022
2022-04-14 Chinese
监事会决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of a company regarding the approval of various reports and proposals including the 2021 Annual Report, 2022 Q1 Report, 2021 Financial Statements, Supervisory Board Work Report, Internal Control Self-Evaluation Report, asset impairment provision, appointment of auditors, and profit distribution plan. The document states that the full reports are disclosed elsewhere (on a regulatory website and newspapers) and that these items still require shareholder approval. The document length is short (2508 characters) and it mainly announces the passing of these reports and proposals rather than containing the full reports themselves. Therefore, this document is an announcement of resolutions and approvals related to reports, not the reports themselves. This fits best with the category of Regulatory Filings (RNS), as it is a formal regulatory announcement of board resolutions and approvals without substantive financial data or full report content.
2022-04-14 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.